U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Prevention of fescue toxicosis

Patent 4880632 Issued on November 14, 1989. Estimated Expiration Date: Icon_subject September 8, 2007. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Method of controlling emesis caused by cisplatin in cancer chemotherapy
Patent #: 4536386
Issued on: 08/20/1985
Inventor: Keenan

Method for percutaneously administering metoclopramide
Patent #: 4605670
Issued on: 08/12/1986
Inventor: Saito ,   et al.

Prolonged release microcapsules and their production
Patent #: 4711782
Issued on: 12/08/1987
Inventor: Okada ,   et al.

Methods of treating and preventing tall fescue toxicosis by the administration of thiamin Patent #: 4755519
Issued on: 07/05/1988
Inventor: Dougherty ,   et al.

Inventors

Assignee

Application

No. 093951 filed on 09/08/1987

US Classes:

424/425, Diffusion barrier is matrix424/422, Implant or insert424/442, Animal food424/486, Synthetic polymer514/617, R contains benzene ring514/619Nitrogen in R

Examiners

Primary: Schofer, Joseph L.
Assistant: Curtis, Pili

Attorney, Agent or Firm

International Classes

A61K 009/26
A61K 031/165

Abstract

A method, and compositions, for use in the prevention and treatment of fescue toxicosis in animals, especially cattle, sheep and horses, comprising administering to the animals a dopamine antagonist which does not cause adverse psychological or neurological effects. Useful dopamine antagonists are those specific for D2 receptors including metoclopramide, sulpiride, tiapride, alizapride and other substituted benzamides. The preferred compound is metoclopramide, a substituted benzamide having the formula 4-amino-5 chloro-N-[2-(diethylamino)ethyl]-2-methoxy benzamide monohydrochloride monohydrate. The correct dosage can be determined from the combination of the behavioral response of the animal to the compound and by measuring the serum prolactin levels over time.In the preferred method, the compound is administered to the animals orally, using capsules, timed or slow release boluses, or as an additive in a salt, mineral, protein or energy block or animal feed, or as an implant.

Other References

  • Lipham et al., Proc. Soc. Exper. Biol. Med. 184, 250-255 (1987)
  • Robbins et al., Appl. Environ. Microbiol. 35, 576-581 (1977)
  • Stuedemann et al., J. Anim. Sci. 63 (Suppl. 1), 290-291 (1986)
  • Stuedemann et al., Am J. Vet. Res. 46, 1990-1995 (1985)
  • Monroe et al., J. Anim. Sci. (Suppl. 1), 50 (1987)
  • Henson et al., Domestic Animal Endocrinology 4 (1), 7-15 (1987).
  • Bolt et al., J. Anim. Sci. 115, 48 (1982)
  • Hurley et al., J. Anim. Sci. 51 (2), 374-379 (1981)
  • Gorewit, J. Endocrinol. Invest. 4, 135-139 (1981)
  • Meltzer et al., Life Sci. 19, 1073-1078 (1976)
  • Lipham et al., Am. J. Vet. Res. 47 (5), 1089-1091 (May 1986)
  • "Pharmacologic Modulation of Serum Concentrations: Implications for Antagonism of Fescue Toxicosis in Cattle" by Luke Blair Lipham, A Dissertation presented to Graduate Faculty of the University of Georgia, Athens, GA. (1988), pp. 1-6
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?